BackKontafarma China Holdings Overview

Kontafarma China Holdings Receivables

Track Kontafarma China Holdings's receivables ($170M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$171.11M
↓ 16.59% YoYΔ $-34.04M vs prior year quarter

Peer trimmed avg / median

Loading

Kontafarma China Holdings Receivables History

Loading

Kontafarma China Holdings vs. peers: Receivables Comparison

Loading

Kontafarma China Holdings Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Kontafarma China Holdings (1312.HK) FAQ

As of the most recent data (June 2026), 1312.HK shows a receivables of $170M. That compares with $210M in the prior-year period — down 16.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 1312.HK's receivables is now $170M (was $210M) — a 16.6% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Kontafarma China Holdings is outperforming or lagging.

Tracking 1312.HK's receivables over time shows whether Kontafarma China Holdings is scaling, shrinking, or reshaping that part of the business. The current reading is $170M That compares with $210M in the prior-year period — down 16.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Kontafarma China Holdings's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $170M) with ownership activity and broader fundamentals.